Jan. 12, 202 — Abbott and AtaCor Medical have announced a collaboration to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to ...
EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
-
-
Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation procedures inside cardiac catheterization and electrophysiology (EP) labs. Several ...
-
Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation robotic system, GenesisX. GenesisX is the latest advance in endovascular surgical ...
-
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple drug classes available, nearly 70% of adults have uncontrolled blood pressure.2 ...
Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...
January 22, 2026
Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...
January 21, 2026
Jan. 12, 202 — Abbott and AtaCor Medical have announced a collaboration to advance a next-generation investigational ...
January 13, 2026Sponsored Content
Blog | ECG
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
August 24, 2022
Feature | Kyle Hardner
Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...
January 09, 2026
Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...
January 06, 2026
Dec. 22, 2025 — Abbott recently announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt ...
January 05, 2026Sponsored Content
Blog | ECG
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
August 24, 2022
Dec. 19, 2025 — Johnson & Johnson MedTech has announced its sponsorship of a new data collection platform developed by ...
December 19, 2025
Dec. 3, 2025 — Recross Cardio Inc., a structural heart company developing next-generation membrane sealing technology ...
December 04, 2025
Nov. 10, 2025 — Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its latest generation ...
November 11, 2025Sponsored Content
Case Study | Cardiovascular Information Systems (CVIS)
Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...
April 01, 2021
Oct. 22, 2025 -- Medical robotics innovator Noah Medical presented two new data sets highlighting the clinical and ...
November 03, 2025
Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...
October 13, 2025
Oct. 10, 2025 — Berlin Heals Holding AG, a clinical-stage medical device company focused on revolutionizing the care of ...
October 13, 2025Sponsored Content
Feature | ECG
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
March 11, 2020
Feature | Renal Denervation | Kyle Hardner
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...
October 02, 2025
Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation ...
September 30, 2025
Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...
September 23, 2025